The Valley Desk

NCT01565668 · Interventional trial

Open Label Study to Evaluate Safety and Efficacy of 2 Doses of Quizartinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Overall registry status Completed

Phase 2

Conditions Leukemia, Myeloid, Acute

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov